Key Metrics
18.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
15 - 20
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
150
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.89
5-Year SI
5-year SI
- 0.88 2-year SI
- 0.87 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cancer Research
- Q1 Neurology (clinical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
3.17
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
13%
4 to 6 months
67%
7 to 9 months
13%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Overall survival
- Cell growth
- Cancer
- Gene expression
- Meningioma
- Antigen
- Temozolomide
- Irradiation
- Central nervous system
- Glioma
- Immunotherapy
- Extracellular vesicles
- Glioblastoma
- Toxicity
- Machine learning
- Proteasome
- Epidermal growth factor receptor
- Germline
- Ependymoma
- Medulloblastoma
Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Neuro-Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Canonical Amplifications and CDKN2A/B Loss Refine IDH1/2-mutant Astrocytoma Prognosis.
- 25 Nov 24
- Neuro-oncology
-
Full paper
Dynamic contrast-enhanced and diffusion-weighted MR imaging for predicting tumor growth of sporadic vestibular schwannomas: a prospective study.
- 23 Nov 24
- Neuro-oncology
-
Full paper
Inhibition of Mitochondrial Bioenergetics and Hypoxia to Radiosensitize Diffuse Intrinsic Pontine Glioma.
- 22 Nov 24
- Neuro-oncology
-
Full paper
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus (EBV) positive and negative primary CNS lymphomas.
- 22 Nov 24
- Neuro-oncology
-
Full paper
EANO guideline on molecular testing of meningiomas for targeted therapy selection.
- 22 Nov 24
- Neuro-oncology
-
Full paper
G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target ATRX-deficient malignant glioma.
- 21 Nov 24
- Neuro-oncology
Scite analysis
Powered by scite_
24.5k articles received 182.1k citations see all
- 6,743 Supporting
- 171,608 Mentioning
- 931 Contrasting
Editorial notices
- 8 Retractions
- 0 Withdrawals
- 4 Corrections
- 51 Errata
- 0 Expression of Concern
FAQs
How long has Neuro-Oncology been actively publishing?
Neuro-Oncology has been in operation since 1999 till date.
What is the publishing frequency of Neuro-Oncology ?
Neuro-Oncology published with a Monthly frequency.
How many articles did Neuro-Oncology publish last years ?
In 2023, Neuro-Oncology published 2326 articles.
What is the eISSN & pISSN for Neuro-Oncology ?
For Neuro-Oncology,eISSN is 1523-5866 and pISSN is1522-8517.
What is Citescore for Neuro-Oncology ?
Citescore for Neuro-Oncology is 18.8.
What is H index for Neuro-Oncology ?
H index for Neuro-Oncology is 150.
What is SNIP score for Neuro-Oncology ?
SNIP score for Neuro-Oncology is 3.17.
What is the SJR for Neuro-Oncology ?
SJR for Neuro-Oncology is Q1.
Who is the publisher of Neuro-Oncology ?
OXFORD UNIV PRESS INC is the publisher of Neuro-Oncology.